Company: VRCA
Filing Date: 2025-04-30
Form Type: DEFR14A
Source: 0001193125-25-105562
Chunk: 0

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-30
Form: DEFR14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box:

| ☐ | Preliminary Proxy Statement |

| ☐ | Confidential, for Use of the Commission Only (as permitted byRule14a-6(e)(2)) |

| ☒ | Definitive Proxy Statement |

| ☐ | Definitive Additional Materials |

| ☐ | Soliciting Materialunder § 240.14a-12 |

Verrica Pharmaceuticals Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply)

| ☒ | No fee required |

| ☐ | Fee paid previously with preliminary materials |

| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules14a-6(i)(1)and 0-11 |

### EXPLANATORY NOTE
Verrica Pharmaceuticals Inc. (the “Company”) is filing the accompanying revised Proxy Statement on Schedule 14A to (i) include certain Inline eXtensible Business Reporting Language data tagging relating to the Company’s disclosure of its policies and practices related to the grant of certain equity awards, which was inadvertently omitted from the original Proxy Statement, (ii) correct the number of shares outstanding and eligible to vote on the record date, which was inadvertently incorrectly specified on pages 1 and 6 of the original Proxy Statement and (iii) correct the number of shares that must be present in person or represented by proxy at the Annual Meeting (as defined below) to have a quorum, which was inadvertently incorrectly specified on page 6 of the original Proxy Statement. There are no other modifications or updates to any disclosures included in the original Proxy Statement.

VERRICA PHARMACEUTICALS INC. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held On June 5, 2025 Dear Stockholder: The Annual Meeting of Stockholders of Verrica Pharmaceuticals Inc. (the “Company”) will be held at the Company’s headquarters, located at 44 W. Gay St., Suite 400, West Chester, Pennsylvania 19380, on Thursday, June